
EMBER-3 data show switching to the combination at progression nearly doubled PFS versus imlunestrant alone in ESR1-mutated advanced breast cancer.
The "Melt the Phones" campaign is just one of the most recent ways that independent pharmacies and other organizations are working toward DIR reform.
Today's episode features Doug Hoey and guests Brian Caswell, Ronna Hauser, and Karry La Violette from NCPA who discuss the "Melt the Phones" campaign and other moving parts of pharmacy DIR.






